“…The following data were extracted for each subject: (a) sociodemographic variables, inclosing year of birth, location of the primary healthcare clinic, sociodemographic status score (as defined in the Supplementary, http://links.lww.com/OLQ/A960), and population sector (Israeli Arabs, Ultraorthodox Jews, and the general sector, based on the place of residence); (b) healthcare services utilization, including purchase of HIV-PrEP, purchase of PDE5 inhibitors (introduced as a potential marker of sexual activity), [8][9][10] utilization of primary healthcare services, the performance of STI tests (urine, pharyngeal, or rectal polymerase chain reaction [PCR] tests for chlamydia and N. gonorrhoeae), vaccines utilization (COVID-19, human papillomavirus [HPV], hepatitis A, and hepatitis B); and (c) STIs, including HIV/AIDS, syphilis, and chlamydia or N. gonorrhoeae detected in urine, pharyngeal, or rectal PCR tests. The number of urine, pharyngeal, or rectal PCR tests performed was extracted for a period of 18 months before the study (January 2021-June 2022).…”